查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889467

醫療設備材料市場預測至2032年：按材料類型、應用、最終用戶和地區分類的全球分析

Medical Device Materials Market Forecasts to 2032 - Global Analysis By Material Type (Plastics, Elastomers, Metals, Ceramics, Composites, Adhesives, Coatings and Films & Foams), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球醫療設備材料市場價值將達到 850 億美元，到 2032 年將達到 1,364.9 億美元，在預測期內的複合年成長率為 7.0%。

醫療設備材料是安全、可靠、有效的醫療設備的基礎，這些器械廣泛應用於診斷、治療和手術。這些材料的選擇是基於其生物相容性、強度、耐化學性和承受嚴格滅菌工藝的能力。不銹鋼和鈦等金屬是植入和手術器械的必備材料，而矽膠、聚氨酯和聚乙烯等聚合物則為各種對患者友好的器械提供了柔軟性。陶瓷和複合材料則用於需要高精度和強組織相互作用的特殊應用。隨著醫療技術的進步，新材料的不斷創新持續推動著器材性能的提升、使用壽命的延長和臨床療效的改善，為現代醫學的發展做出了重大貢獻。

據印度生物技術企業聯合會 (IBEF) 稱，印度 70-80% 的醫療設備從美國、中國和德國等國家進口，這表明印度對全球專業醫療級材料的供應鏈高度依賴。

擴大微創手術的使用

微創手術的普及顯著推動了醫療設備材料市場的發展，其驅動力在於人們需要盡可能減少不適感、縮短恢復時間和減少住院時間。這些手術依賴高性能材料來確保生物相容性、強度和柔軟性，包括支架、導管導引線、導管和其他精密器械。聚氨酯、矽膠和聚四氟乙烯（PTFE）等先進聚合物以及鎳鈦諾等形狀記憶金屬能夠實現順暢的操作和長期的功能性。隨著患者擴大選擇創傷較小的治療方案，以及醫療系統更加重視成本效益，對輕質、耐用和微型化材料的需求持續成長，進一步推動了市場的擴張。

先進醫療材料高成本

新一代醫用材料的高成本是限制醫療設備材料市場成長的主要障礙。諸如特種合金、奈米材料、生物可吸收聚合物和高純度鈦等先進材料，研發和生產成本高昂，且通常需要複雜的加工過程和嚴格的品質標準。這些因素顯著增加了生產成本，使得中小醫療器材製造商難以與之競爭。材料成本的上漲也導致產品價格上漲，這可能會限制醫院的採購決策，並降低病患的就醫機會。因此，成本壓力阻礙了創新材料的廣泛應用，並減緩了技術先進的醫療設備的整體普及速度。

拓展個人化醫療和精準醫療

隨著醫療保健朝著個人化治療和患者客製化解決方案的方向發展，對個人化和精準醫療的日益重視為醫療設備材料市場帶來了巨大的機會。客製化植入、個人化手術器械、先進的穿戴式設備和標靶藥物傳輸平台都依賴具有卓越生物相容性、柔軟性和適應性的材料。智慧聚合物、生物可吸收化合物和3D列印材料等創新技術使得設計能夠貼合患者解剖結構和治療需求的醫療設備成為可能。隨著全球對客製化醫療解決方案的需求不斷成長，對先進材料技術的需求也相應增加。這種轉變正在推動持續創新，並透過支援高階、高附加價值醫療設備的開發來增強市場實力。

來自低成本製造商的競爭日益加劇

來自低成本生產商日益激烈的競爭對醫療設備材料市場構成威脅，尤其是對那些專注於高階先進材料的公司而言。新興經濟體的供應商往往由於製造成本較低、監管環境彈性以及有利的地區政策，能夠提供價格較低的材料。這種成本優勢迫使老牌製造商降低價格並調整營運模式。雖然低成本材料可能在性能或認證方面有所欠缺，但對於注重預算的醫療器材製造商來說，它們仍然具有吸引力。面對這些競爭對手日益成長的影響力，高階製造商在價格敏感的市場環境中，難以維持定價權、鞏固市場地位並展現尖端材料技術的價值。

新冠疫情的影響：

新冠疫情對全球製造業活動產生了重大影響，為醫療設備材料市場帶來了挑戰和機會。初期封鎖和運輸限制延緩了金屬、聚合物和特殊材料的採購，導致多種非緊急醫療設備的產量下降。同時，人工呼吸器、偵測設備、個人防護工具（PPE）和一次性醫療用品所需的材料需求激增。製造商迅速調整生產以滿足緊急醫療需求，推動了對高性能聚合物和生物相容性材料的需求成長。雖然擇期手術暫時減少，但必需醫療設備產量的增加有助於平衡市場壓力，並促進材料的長期創新。

預計在預測期內，塑膠產業將佔據最大的市場佔有率。

由於塑膠具有適應性強、價格實惠且適用於多種醫療應用等優點，預計在預測期內，塑膠領域將佔據最大的市場佔有率。塑膠易於模製成各種複雜形狀，並具有優異的生物相容性、耐化學性和與各種滅菌工藝的兼容性。這些特性使得塑膠成為一次性醫療器材、診斷組件、導管、設備機殼和控釋藥物產品等產品不可或缺的材料。聚丙烯、聚乙烯、聚氯乙烯、聚碳酸酯和矽酮等常用材料因其強度高、柔軟性和可靠性強而備受青睞。隨著醫療產業日益重視輕量化、高效且經濟的解決方案，塑膠仍然是醫療設備製造的首選材料。

預計在預測期內，醫療穿戴裝置領域將呈現最高的複合年成長率。

在預測期內，醫療穿戴式裝置領域預計將保持最高的成長率，這主要得益於數位化醫療的加速普及和對持續病患監測日益成長的需求。這些設備需要採用柔軟、柔軟性、親膚且經久耐用的材料，以確保使用者佩戴舒適。彈性體、先進聚合物、導電基板和透氣薄膜等領域的創新，提升了感測器的性能，並實現了設備的無縫整合。遠端醫療服務的擴展、對慢性病追蹤、健身監測和個人化健康解決方案需求的成長，都推動了對特種材料的需求。隨著醫療保健領域日益互聯互通和以用戶為中心，穿戴式裝置材料的需求將持續強勁成長。

佔比最大的地區：

在預測期內，北美預計將保持最大的市場佔有率，這得益於其先進的醫療基礎設施、有利的法規環境以及對醫療創新的堅定承諾。高昂的人均醫療費用支出、日益老化的人口以及先進醫療技術的廣泛應用，推動了對複雜植入、診斷設備、手術器械和高階耗材的高需求。主要醫療設備製造商的集中、高效的報銷政策以及大量的研發投入，進一步鞏固了該地區的主導地位。因此，北美將繼續保持全球主導地位，佔據醫療設備市場最大的佔有率。

複合年成長率最高的地區：

預計亞太地區在預測期內將呈現最高的複合年成長率。該地區的成長主要得益於醫療基礎設施的不斷改善、醫療支出的持續成長，以及中國、印度和日本等人口眾多且持續成長的國家所帶來的需求增加。此外，醫療設備產能的提升、現代醫療技術的日益普及以及慢性病發病率的上升也進一步刺激了需求。政府推出的扶持政策，例如促進國內生產和改善醫療服務，也扮演了重要角色。因此，亞太地區在全球醫療設備材料領域展現出最強勁的成長動能與市場潛力。

免費客製化服務：

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家的市場規模和複合年成長率進行估算和預測（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章 全球醫療設備材料市場（依材料類型分類）

  • 塑膠
  • 彈性體
  • 金屬
  • 陶瓷
  • 複合材料
  • 黏合劑
  • 塗層
  • 薄膜和泡沫

第6章 全球醫療設備材料市場（依應用領域分類）

  • 醫療設備
  • 一次性產品
  • 穿戴式醫療設備
  • 進階創傷護理
  • 醫療包裝

第7章 全球醫療設備材料市場（依最終用戶分類）

  • 醫院和診所
  • 門診手術中心
  • 居家醫療
  • 研究和學術機構

第8章 全球醫療設備材料市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章：重大發展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：企業概況

  • Evonik Industries AG
  • Covestro AG
  • Royal DSM NV
  • BASF SE
  • Lonza Group AG
  • Merck KGaA
  • Celanese Corporation
  • Arkema SA
  • Wacker Chemie AG
  • DuPont Liveo
  • B. Braun Melsungen AG
  • Solvay
  • Sabic
  • Teknor Apex
  • Lubrizol
Product Code: SMRC32765

According to Stratistics MRC, the Global Medical Device Materials Market is accounted for $85.0 billion in 2025 and is expected to reach $136.49 billion by 2032 growing at a CAGR of 7.0% during the forecast period. Medical device materials form the foundation of safe, reliable, and effective healthcare equipment used in diagnosis, treatment, and surgery. These materials are chosen for their biocompatibility, strength, chemical resistance, and ability to withstand rigorous sterilization. Metals such as stainless steel and titanium are essential for implants and surgical instruments, while polymers including silicone, polyurethane, and polyethylene offer flexibility for various patient-friendly devices. Ceramics and composite materials serve specialized purposes requiring precision and strong tissue interaction. With ongoing advancements in healthcare, new material innovations continue to enhance device performance, extend operational life, and support better clinical results, contributing significantly to modern medical progress.

According to IBEF, India imports 70-80% of its medical devices from countries such as the US, China, and Germany, which highlights the reliance on global supply chains for specialized medical-grade materials.

Market Dynamics:

Driver:

Growing adoption of minimally invasive procedures

The expanding use of minimally invasive surgeries significantly boosts the medical device materials market, driven by the need for procedures that minimize discomfort, shorten healing time, and reduce hospitalization. These interventions depend on high-performance materials that ensure biocompatibility, strength, and flexibility for devices such as stents, guidewires, catheters, and other precision tools. Advanced polymers like polyurethane, silicone, and PTFE, as well as shape-memory metals such as nitinol, enable smooth navigation and long-term function. With patients increasingly choosing less invasive options and healthcare systems focusing on cost efficiency, the requirement for lightweight, durable, and miniaturized materials continues to rise, fueling broader market expansion.

Restraint:

High cost of advanced medical materials

The elevated cost of next-generation medical materials poses a major barrier to growth in the medical device materials market. Advanced options like specialty alloys, nanomaterials, bioresorbable polymers, and high-purity titanium are expensive to develop and manufacture, often requiring intricate processing methods and rigorous quality standards. These factors significantly raise production costs and make it difficult for smaller device makers to compete. Higher material expenses also translate into increased product prices, which can limit purchasing decisions among hospitals and reduce patient accessibility. As a result, cost pressures hinder broader adoption of innovative materials and slow the overall expansion of technologically advanced medical devices.

Opportunity:

Expansion of personalized and precision medicine

The growing focus on personalized and precision medicine creates major opportunities within the medical device materials market, as healthcare moves toward tailored treatments and patient-specific solutions. Customized implants, individualized surgical instruments, advanced wearables, and targeted drug-delivery platforms depend on materials that provide superior biocompatibility, flexibility, and adaptability. Innovations such as smart polymers, bioresorbable compounds, and 3D-printable materials make it possible to design devices that match patient anatomy or therapeutic requirements. As global demand for customized medical solutions increases, the need for advanced material technologies rises accordingly. This shift drives continuous innovation and strengthens the market by supporting premium, high-value device development.

Threat:

Rising competition from low-cost manufacturers

Increasing competition from low-cost producers threatens the medical device materials market, especially for companies specializing in high-end, advanced materials. Suppliers in emerging economies often offer significantly cheaper materials due to lower manufacturing expenses, flexible regulations, and favorable local policies. This cost-based advantage puts pressure on established manufacturers to cut prices or adapt their operations. Although low-cost options may lack top-tier performance or certification, they remain attractive to budget-conscious device makers. As these competitors expand their presence, premium manufacturers struggle to maintain pricing power, safeguard their market position, and highlight the value of their advanced material technologies in a price-sensitive environment.

Covid-19 Impact:

The COVID-19 pandemic created both challenges and opportunities for the medical device materials market by significantly affecting global manufacturing activity. Early lockdowns and transport restrictions led to delays in sourcing metals, polymers, and specialty materials, resulting in reduced output for several non-urgent medical devices. At the same time, demand increased sharply for materials required for ventilators, testing equipment, PPE, and disposable medical supplies. Manufacturers shifted quickly to meet emergency healthcare needs, driving growth in high-performance polymers and biocompatible materials. Although elective surgeries dropped temporarily, the boost in essential medical device production helped balance market pressures and encouraged long-term material innovation.

The plastics segment is expected to be the largest during the forecast period

The plastics segment is expected to account for the largest market share during the forecast period, primarily because of their adaptability, affordability, and suitability for numerous medical uses. They can be easily shaped into intricate forms and offer strong biocompatibility, excellent chemical resistance, and compatibility with various sterilization processes. These qualities make plastics essential for disposable instruments, diagnostic parts, tubing, device casings, and controlled drug-delivery products. Common materials such as polypropylene, polyethylene, PVC, polycarbonate, and silicone polymers are favored for their strength, flexibility, and reliability. As the healthcare industry increasingly prioritizes lightweight, efficient, and cost-friendly solutions, plastics remain the dominant choice for medical device manufacturing.

The medical wearables segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the medical wearables segment is predicted to witness the highest growth rate, driven by accelerating digital health adoption and increasing reliance on continuous patient monitoring. These devices depend on materials that deliver softness, flexibility, skin-friendliness, and long-term durability, ensuring users can wear them comfortably for extended periods. Innovations in elastomers, advanced polymers, conductive substrates, and breathable films support improved sensor function and seamless device integration. Growth in remote health services, chronic condition tracking, fitness monitoring, and personalized wellness solutions boosts the need for specialized materials. With healthcare becoming more connected and user-centric, wearable device materials continue to record strong expansion and rising demand.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, thanks to its sophisticated healthcare infrastructure, favorable regulatory environment, and strong commitment to medical innovation. High demand for complex implants, diagnostic equipment, surgical instruments, and premium consumables is driven by significant healthcare spending per person, a growing elderly population, and widespread use of advanced medical technologies. The concentration of major device manufacturers, efficient reimbursement policies, and substantial R&D investments reinforce the region's leadership. Consequently, North America remains the dominant region worldwide, maintaining the largest share in the medical device materials market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Growth there is fueled by expanding healthcare infrastructure, higher medical expenditures, and rising demand driven by large and growing populations in countries such as China, India, and Japan. The region's increased capacity for device manufacturing, growing adoption of modern medical technology, and rising incidence of chronic diseases further stimulate demand. Supportive governmental policies encouraging domestic production and improved access to healthcare also play a strong role. As a result, Asia-Pacific demonstrates the strongest growth trajectory and market potential in the medical device materials sector worldwide.

Key players in the market

Some of the key players in Medical Device Materials Market include Evonik Industries AG, Covestro AG, Royal DSM N.V., BASF SE, Lonza Group AG, Merck KGaA, Celanese Corporation, Arkema S.A., Wacker Chemie AG, DuPont Liveo, B. Braun Melsungen AG, Solvay, Sabic, Teknor Apex and Lubrizol.

Key Developments:

In November 2025, Covestro AG and Abu Dhabi's XRG have secured the final regulatory green light for their strategic partnership, winning approval from Germany's Federal Ministry for Economic Affairs and Energy. The decision clears the last remaining hurdle under foreign investment rules, setting the stage for the deal to close within days. The partnership-positioned as a transformative move for the global chemicals sector-will see the two companies push aggressively into innovation, circular production, and digital transformation.

In October 2025, BASF SE and ANDRITZ Group have signed a license agreement for the use of BASF's proprietary gas treatment technology, OASE(R) blue, in a carbon capture project planned to be implemented in the city of Aarhus, Denmark. The project aims to capture approximately 435,000 tons of CO2 annually from the flue gases of a waste-to-energy plant for sequestration; the city of Aarhus has set itself the goal of becoming CO2-neutral by 2030.

In March 2025, Evonik has entered into an exclusive agreement with the Cleveland-based Sea-Land Chemical Company for the distribution of its cleaning solutions in the U.S. The agreement builds on a long-standing relationship with the distributor and expands the reach of Evonik's cleaning solutions to the entire U.S. region.

Material Types Covered:

  • Plastics
  • Elastomers
  • Metals
  • Ceramics
  • Composites
  • Adhesives
  • Coatings
  • Films & Foams

Applications Covered:

  • Medical Devices
  • Disposables
  • Medical Wearables
  • Advanced Wound Care
  • Medical Packaging

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Research & Academic Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Device Materials Market, By Material Type

  • 5.1 Introduction
  • 5.2 Plastics
  • 5.3 Elastomers
  • 5.4 Metals
  • 5.5 Ceramics
  • 5.6 Composites
  • 5.7 Adhesives
  • 5.8 Coatings
  • 5.9 Films & Foams

6 Global Medical Device Materials Market, By Application

  • 6.1 Introduction
  • 6.2 Medical Devices
  • 6.3 Disposables
  • 6.4 Medical Wearables
  • 6.5 Advanced Wound Care
  • 6.6 Medical Packaging

7 Global Medical Device Materials Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals & Clinics
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Home Healthcare
  • 7.5 Research & Academic Institutes

8 Global Medical Device Materials Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Evonik Industries AG
  • 10.2 Covestro AG
  • 10.3 Royal DSM N.V.
  • 10.4 BASF SE
  • 10.5 Lonza Group AG
  • 10.6 Merck KGaA
  • 10.7 Celanese Corporation
  • 10.8 Arkema S.A.
  • 10.9 Wacker Chemie AG
  • 10.10 DuPont Liveo
  • 10.11 B. Braun Melsungen AG
  • 10.12 Solvay
  • 10.13 Sabic
  • 10.14 Teknor Apex
  • 10.15 Lubrizol

List of Tables

  • Table 1 Global Medical Device Materials Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Medical Device Materials Market Outlook, By Material Type (2024-2032) ($MN)
  • Table 3 Global Medical Device Materials Market Outlook, By Plastics (2024-2032) ($MN)
  • Table 4 Global Medical Device Materials Market Outlook, By Elastomers (2024-2032) ($MN)
  • Table 5 Global Medical Device Materials Market Outlook, By Metals (2024-2032) ($MN)
  • Table 6 Global Medical Device Materials Market Outlook, By Ceramics (2024-2032) ($MN)
  • Table 7 Global Medical Device Materials Market Outlook, By Composites (2024-2032) ($MN)
  • Table 8 Global Medical Device Materials Market Outlook, By Adhesives (2024-2032) ($MN)
  • Table 9 Global Medical Device Materials Market Outlook, By Coatings (2024-2032) ($MN)
  • Table 10 Global Medical Device Materials Market Outlook, By Films & Foams (2024-2032) ($MN)
  • Table 11 Global Medical Device Materials Market Outlook, By Application (2024-2032) ($MN)
  • Table 12 Global Medical Device Materials Market Outlook, By Medical Devices (2024-2032) ($MN)
  • Table 13 Global Medical Device Materials Market Outlook, By Disposables (2024-2032) ($MN)
  • Table 14 Global Medical Device Materials Market Outlook, By Medical Wearables (2024-2032) ($MN)
  • Table 15 Global Medical Device Materials Market Outlook, By Advanced Wound Care (2024-2032) ($MN)
  • Table 16 Global Medical Device Materials Market Outlook, By Medical Packaging (2024-2032) ($MN)
  • Table 17 Global Medical Device Materials Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global Medical Device Materials Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 19 Global Medical Device Materials Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 20 Global Medical Device Materials Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 21 Global Medical Device Materials Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.